Understanding the GLP-1R Palmitoylation Mechanism for Better Antidiabetes Therapies — PhD Project

Understanding the GLP-1R Palmitoylation Mechanism for Better Antidiabetes Therapies — PhD Project

Project Assessment

This Coventry doctorate connects molecular simulation with experimental receptor pharmacology to investigate a poorly resolved regulatory mechanism of GLP-1R. Its distinctive advantage is the pairing of Giuseppe Deganutti's computational GPCR work with Jennifer Greaves' expertise in protein S-acylation. The work concerns how receptor lipid modification occurs and changes function; the established clinical relevance of GLP-1 drugs does not establish this project's proposed mechanism or a new treatment benefit.

The saved October 2026 university call lists this project for 2027 entry, with applications opening 12 October 2026 and closing 23 November 2026. No closing time or time zone is published, and current acceptance status has not been verified. Coventry explicitly covers the international tuition difference alongside the MIBTP studentship. Eligible international applicants may compete, subject to selection. The next useful conversation is about the initial enzyme question, the balance of computation and experiments, and individual award dates. Saved Coventry 2027 project and funding information, original FindAPhD listing

Research Problem and Doctoral Work

GLP-1R is a class B GPCR involved in metabolic regulation. Palmitoylation is a reversible protein-lipid modification that may alter receptor organisation, interactions and signalling. The advertised knowledge gap concerns the enzymes responsible and the structural and functional consequences of this modification. It is not a claim that receptor lipid regulation has never been studied. An external 2019 original study already connected agonist-induced membrane organisation with receptor responses and identified enzyme definition and further dynamic analysis as unresolved directions. That paper is foundational context, not a recent publication by the named supervisors. Official project outline, external foundational original

The doctorate has three advertised strands: identify the specific S-acylases and deacylases involved in GLP-1R palmitoylation and examine structural interactions involving the receptor; use molecular-dynamics simulations to compare palmitoylated and non-palmitoylated GLP-1R, examining receptor flexibility, membrane anchoring and interactions with signalling partners; then use cell-based assays, including click chemistry, signalling assays and confocal microscopy, to study effects on receptor localisation, stability and activity. These are the advertised directions and method categories; candidate enzymes, validated models and the final experimental plan are not specified.

The central inference problem is connecting a molecular change to a functional consequence. A simulation can suggest altered flexibility or membrane association, but its trajectory is conditional on the model and sampled states. An experimental change in signalling may reflect receptor abundance, location or interactions rather than the structural explanation alone. Distinguishing these possibilities is a research objective. Agreement between selected simulation features and one assay is less persuasive than a coherent explanation across independent structural and functional observations.

A useful early milestone would be a bounded question and an agreed standard for interpreting disagreement between computation and experiment. The announcement leaves the enzyme-discovery strategy, model validation criteria, datasets, computing allocation and experimental responsibilities unspecified. These should become a realistic supervisory plan, not assumptions about immediate access to every technique in collaborators' papers. Better therapies are a possible long-term consequence of mechanistic insight, not a promised doctoral output or clinical claim.

School, Programme and Field Context

Coventry University is the registration institution. The project-specific PGR+ entry identifies this exact project under DLSR002, Clinical Sciences and Translational Medicine. The research is hosted in the Centre for Discoveries in Life Sciences. The MIBTP profile explicitly names Coventry registration; six partner universities do not imply a joint degree or permission to move registration freely. Exact application entry, project registration

DLS describes expertise spanning cell biology, pharmacology, biochemistry and metabolic physiology, with industry links, Knowledge Transfer Partnerships and spin-outs. Its official page also describes Royal Society of Biology doctoral-training accreditation under an older centre name. This supports the training environment, but the applicable programme/accreditation scope should be confirmed rather than treated as a professional licence. Specific compute quotas, microscopy access and technical support have not been allocated publicly to this student. DLS environment

Coventry is joint 581st in QS World University Rankings 2027, an overall institutional position rather than a pharmacology or supervisor ranking. For this specialised opportunity, the supervisors' complementary methods and current papers are more direct evidence than the overall rank. There is no verified project-level placement or salary statistic. QS institutional ranking

MIBTP describes a four-year programme, combining cohort training, research mini-projects, a three-month professional internship and masterclasses across partner institutions. This offers breadth beyond a single laboratory. Placements require planning and are not a guaranteed named pharmaceutical employer. The Coventry table lists this project among ordinary PhD opportunities, separately from industrial CASE posts; their compulsory industrial arrangements must not be transferred here. Individual registration, funded dates and any completion-period support should still be confirmed. MIBTP training FAQ

Supervisor and Lab Assessment

The university's February 2026 announcement identifies Dr Giuseppe Deganutti as Assistant Professor in DLS. His MIBTP profile confirms primary supervision and ad5288@coventry.ac.uk. Professor Jennifer Greaves is explicitly the secondary supervisor; her research concerns S-acylation and the enzymes regulating it. This is a meaningful computational/chemical-biology combination. Other coauthors are evidence of collaboration, not additional appointed supervisors. Deganutti role, Greaves expertise

Deganutti states a preference for taking responsibility for first-year technical training, expects weekly progress updates, and schedules individual meetings at least weekly in years one to three and group meetings at least monthly. Meetings mix in-person and remote formats. Work timing is flexible around agreed meetings; written work up to 5,000 words needs at least two weeks for feedback. Team messaging may occur during weekdays and weekends, alongside an explicit work-life-balance expectation. Confirm how Greaves participates and how this pattern extends through year four. Supervision commitments

Three recent Deganutti-coauthored original studies show relevant capabilities, with unequal reading depth:

Deganutti and colleagues, Nature Communications, 2022

Structural, simulation and functional comparisons across receptor agonists link dynamic engagement to G-protein activation kinetics. The complete institutional original abstract and a substantive original indexed discussion passage were read. Similar active-state contacts need not imply identical dynamics; this is not evidence identifying the palmitoylation enzymes. Full main methods/results and supplementary data were not audited. 2022 original

Mariam and colleagues, BBRC, 2025

Computational analysis of a dimeric incretin proposes a possible allosteric auto-modulation explanation. The complete original institutional abstract was read; main-text methods/results were not. The proposed mechanism is a model-based interpretation, not proof of clinical superiority or this project's lipid-modification mechanism. 2025 computational original

Cary and colleagues, PNAS, 2025

Receptor responses can remain prolonged despite different trafficking behaviour. The complete original institutional abstract and an original indexed discussion excerpt were read. This supports separating signalling duration, location and molecular dynamics, not collapsing them into one efficacy measure. It does not establish patient outcomes or the enzyme mechanism proposed here. 2025 signalling original

These are three original journal papers, not three fully read papers. A separate Leverhulme-supported GPCR collaboration with Cambridge and Imperial is evidence of current research activity, not this student's award, travel entitlement or guaranteed access to those institutions.

Funding, Application, and Living Cost

The project-specific Coventry call combines UK-rate tuition, tax-free maintenance and an explicit university contribution covering the international fee difference. International candidates can compete; MIBTP's up-to-30% international-student limit applies to the funded studentship cohort as a whole; it is not a project-specific allocation or an individual's award probability. This positive coverage is stronger than a worldwide label alone. Personal allocation remains competitive, without requiring an applicant to hold an award before discussing the opportunity. Current award components, international eligibility

£21,805 is the 2026/27 annual reference, not a confirmed 2027 personal stipend. The four-year programme framework should not be silently converted into an individual payment schedule. Ask for funded dates, annual uprating, completion support and any uncovered charges. Travel/conference and consumables budgets support research, not unrestricted living cash. A MacBook Pro is available for use during the programme, rather than an unconditional gift.

Cycle Works lists £154–210 per week for 2026/27, with 39-, 43- and 50-week contracts. A 50-week rent illustration is £7,700–10,500; two remaining weeks need a housing plan. Bills and Wi-Fi inclusions should not be added twice. An analyst scenario using 52 weeks at the same rate plus £450–600 monthly for non-rent spending gives approximately £13,408–18,120 annually. This is a budgeting assumption, not a quoted 52-week contract, guaranteed room or 2027 price. Accommodation reference

The government fee references used here for a Student visa and student IHS are £558 and £776 per visa-year. The surcharge is generally paid upfront for the applicable permission period; visa validity may exceed course length. MIBTP states that visa, health-surcharge and travel costs fall to international students. Budget relocation and initial cash separately, without assuming reimbursement. Student visa, IHS

Applicant Fit and Preparation

The advertised academic threshold is a relevant UK 2:1 or equivalent, with project-element and overall-module marks stated at 60% or equivalent. These are UK qualification conditions, not a universal Chinese-university 60% conversion. Current MIBTP guidance permits international equivalent qualifications; Coventry must assess the actual degree and record. The network's normal First/high-2:1 expectations and stated lower-degree exceptions should be read alongside the local call, not used to promise admission. MIBTP eligibility, Coventry research entry

The project names computational biology and molecular pharmacology training without declaring a particular programming language, prior publication or mastery of every advertised method mandatory. Relevant preparation could demonstrate quantitative reasoning, critical interpretation of molecular models and an ability to relate structural hypotheses to biological measurements. Prior simulation or pharmacology work helps explain readiness, but these are analyst suggestions unless the supervisors specify additional requirements. A purely computational ambition should clarify how much experimental participation is expected.

The call gives IELTS Academic 7.0 overall, each component 6.5, or TOEFL iBT 95, each component 21. Coventry's research guidance allows application with an achieved result or evidence of a booked test, normally requiring valid results within two years. Its stated English-medium exemption concerns recent degree-level study in a UKVI majority-English-speaking country; a Chinese English-taught degree does not automatically satisfy it. Current test acceptance and the applicable centre label should be confirmed for the offer.

Complete the EDI expression-of-interest stage separately from the chosen Coventry PGR+ application. The academic directors and shortlisting panel do not see EDI responses. University guidance requests degree documents and, where applicable, original plus notarised English translations; references normally comprise two academic, or one academic and one professional, with institutional credentials. Proposal/cover-letter requirements depend on the actual application checklist. Administrative enquiries go to Katie.Choudhry@coventry.ac.uk. China is not ATAS-nationality-exempt, but applicability depends on the actual research classification and offer, not the presence of a biomedical keyword. Application documents, ATAS

Next Actions and Questions to Verify

Before applying, ask Deganutti which mechanistic uncertainty forms the first-year question, what computational and experimental contribution is expected, and how Greaves' co-supervision operates. The saved materials list 23 November without a time or time zone; confirm current acceptance status and the submission convention, degree equivalence and exact documents before acting. The Coventry PGR+ entry provides a concrete route rather than a generic expression of interest.

At interview, clarify evidence standards for distinguishing receptor abundance, localisation and signalling effects; access to computing, laboratory support and data; and how negative or conflicting findings will be handled. Ask about ownership, publication and external collaboration arrangements. Existing papers' facilities do not establish this student's allocation.

Before accepting, obtain the fee-gap coverage, stipend, funded dates and continuation conditions in writing, and check visa/ATAS requirements and housing cash flow. Computational chemistry and data skills feature in ABPI's 2025 industry analysis, supporting the transferable value of this training. That industry perspective also identifies mobility barriers; it is not a project placement guarantee, salary forecast or automatic immigration route. The opportunity's value lies in learning to connect credible molecular models with defensible functional evidence. Industry skills context

Evidence and Sources

Project, supervisors and original research

• Saved Coventry 2027 MIBTP recruitment and funding information
• Original FindAPhD project listing
• Exact GLP-1R PGR+ entry
• Deganutti project and supervision
• Deganutti current role and research award
• Greaves scientific expertise
• 2022 GLP-1R dynamics original
• 2025 dimeric incretin computational original
• 2025 signalling and trafficking original
• 2019 external foundational original

School, programme and training

• DLS research and doctoral-training environment
• MIBTP programme FAQ
• Coventry QS 2027 overall ranking

Funding, eligibility, costs and careers

• MIBTP international application and funding rules
• Coventry doctoral and English entry requirements
• Coventry application documents
• Cycle Works 2026/27 prices and contracts
• UK Student visa
• UK immigration health surcharge
• ATAS nationality and subject rules
• ABPI 2025 skills and talent analysis